Clinical Trials Browser

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic, Hepatitis C, Chronic

NCT05870969 2023-05-23

dSEARCH

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic, Hepatitis C, Chronic, Non-alcoholic Fatty Liver Disease

NCT05376943 2022-05-17

Possible Differences in HCC Course Depending on DAA Treatment

Unknown

100 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis C, Chronic, Drug-Related Side Effects and Adverse Reactions

NCT02785835 2022-03-16

GEHEP-002

Completed

477 enrolled

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis C, Chronic

NCT04460157 2020-07-07

Prediction of Liver-related Outcomes After HCV Cure

Unknown

1,035 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT03551444 2018-06-11

CAUTIOUS

Phase 3 Unknown

80 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT02319200 2017-01-11

METFOVIR

Phase 3 Terminated

11 enrolled

Gastrointestinal

Death, Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT00375661 2015-09-02

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Phase 4 Completed

100 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT01831037 2015-01-28

ROLFH

Withdrawn

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis B, Chronic, Hepatitis C, Chronic

NCT00834860 2010-02-15

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma

Phase 4 Unknown

179 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms, Hepatitis C, Chronic

Clinical Trials

STOPHCC-GAAD

dSEARCH

Possible Differences in HCC Course Depending on DAA Treatment

GEHEP-002

Prediction of Liver-related Outcomes After HCV Cure

CAUTIOUS

METFOVIR

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

ROLFH

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma